FeesSafety
Pluang+

XRP leads rise in dollar-margin long accounts among top crypto assets, BTC and ETH also gain.

Technical Signals
23 Oct 2026
Tokenpost
View Source
Bullish
XRP leads rise in dollar-margin long accounts among top crypto assets, BTC and ETH also gain.

On October 23, XRP showed the largest increase in dollar-margin long account shares, rising nearly 5 percentage points to 79%, signaling growing bullish sentiment. Bitcoin (BTC) and Ethereum (ETH) also saw notable increases in their dollar-margin long positions and account shares, with BTC's long position share reaching 61% and ETH's coin-margin long position share hitting 80%. Smaller gains were observed for Solana (SOL) and Dogecoin (DOGE). These shifts highlight differing investor preferences between dollar-margin and coin-margin contracts, with XRP leading the bullish trend among the five major cryptocurrencies. Investors should consider both position-based and account-based data to understand the concentration of long exposure in these assets.

XRP futures dollar-margin long accounts rose 4.97 percentage points. For readers following major cryptocurrencies, here is Pluang's market snapshot as of Oct 23, 2026 17:51 WIB: 25 of 50 major cryptocurrencies rose today. BAT traded at Rp3.150 with a 1-day change of +2.35% and Pluang order activity of 34% Sell / 66% Buy. GRT was priced at Rp436, up 1.96%, with 4% Sell / 96% Buy order activity.

More News

Zinc and tin supply shortages revive interest in historic US mining districts with new drilling results.

Zinc and tin supply shortages revive interest in historic US mining districts with new drilling results.

Global zinc supply is expected to fall short by 88,000 tonnes in 2026 amid declining mine production, while tin demand is projected to outpace supply growth through 2035. This has renewed exploration in historic polymetallic mining districts in the U...

Market News
Bullish
18 minutes ago
Avacta's AVA6103 shows promise against Enhertu-resistant tumors in early trial and preclinical data

Avacta's AVA6103 shows promise against Enhertu-resistant tumors in early trial and preclinical data

Avacta Therapeutics presented positive preclinical and early clinical data for AVA6103, a novel peptide-drug conjugate targeting FAP-positive tumors resistant to Enhertu. AVA6103 demonstrated superior tumor control and prolonged drug release in precl...

Market News
Bullish
1 hour ago
Obra Capital closes $403.6M CLO deal, pushing total CLO issuance over $2B in under two years.

Obra Capital closes $403.6M CLO deal, pushing total CLO issuance over $2B in under two years.

Obra Capital has closed its fifth Collateralized Loan Obligation (CLO) offering, raising $403.6 million. This deal brings the firm's total CLO issuance to more than $2 billion across five deals in less than two years, demonstrating strong investor co...

Company Fundamentals
Bullish
1 hour ago
Padeliporfin VTP shows promise in making unresectable pancreatic cancer operable in Phase 1 trial

Padeliporfin VTP shows promise in making unresectable pancreatic cancer operable in Phase 1 trial

ImPact Biotech reported positive early results from its Phase 1 trial of Padeliporfin VTP in patients with locally advanced, unresectable pancreatic cancer. Of 12 patients treated, 75% have undergone or are scheduled for surgery, with over half achie...

Company Fundamentals
Bullish
1 hour ago
eSoftware offers a quick diagnostic to help organizations secure sensitive files before Microsoft 365 Copilot rollout.

eSoftware offers a quick diagnostic to help organizations secure sensitive files before Microsoft 365 Copilot rollout.

eSoftware Associates has introduced a free five-minute AI readiness assessment to help regulated organizations identify and prioritize security risks related to sensitive file access in Microsoft 365 before deploying Copilot. The assessment highlight...

Others
Neutral
2 hours ago
banner-footerbanner-footer

Invest & Trade with
#1 Award-Winning Investment Super App